Here are the DEF 14A proxy statements from ClearPoint Neuro, Inc. (CLPT) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A DEF 14A covers the proxy statement, with executive pay and the shareholder votes, so if you follow CLPT and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CLPT filings page.
ClearPoint Neuro, Inc. is asking stockholders to vote at a virtual-only 2026 Annual Meeting on May 20, 2026 at 10:00 a.m. Pacific Time. Holders of 29,986,016 common shares as of March 23, 2026 may participate.
Stockholders will elect seven directors, ratify Cherry Bekaert LLP as independent auditor, cast an advisory say-on-pay vote on executive compensation, and consider approval of the Seventh Amended and Restated 2013 Incentive Compensation Plan. The revised plan would add 1,000,000 shares, increasing the total plan share reserve to 7,806,250, which the company notes is about 3% of fully diluted shares.